Annual CAPEX
$18.51 M
+$2.06 M+12.49%
31 December 2023
Summary:
ANI Pharmaceuticals annual capital expenditures is currently $18.51 million, with the most recent change of +$2.06 million (+12.49%) on 31 December 2023. During the last 3 years, it has fallen by -$49.81 million (-72.91%). ANIP annual CAPEX is now -87.58% below its all-time high of $149.06 million, reached on 31 December 2016.ANIP CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$5.44 M
+$994.00 K+22.34%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly capital expenditures is currently $5.44 million, with the most recent change of +$994.00 thousand (+22.34%) on 30 September 2024. Over the past year, it has increased by +$890.00 thousand (+19.55%). ANIP quarterly CAPEX is now -93.64% below its all-time high of $85.55 million, reached on 31 March 2016.ANIP Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$19.25 M
+$890.00 K+4.85%
30 September 2024
Summary:
ANI Pharmaceuticals TTM capital expenditures is currently $19.25 million, with the most recent change of +$890.00 thousand (+4.85%) on 30 September 2024. Over the past year, it has increased by +$2.38 million (+14.09%). ANIP TTM CAPEX is now -88.96% below its all-time high of $174.46 million, reached on 30 June 2016.ANIP TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +12.5% | +19.6% | +14.1% |
3 y3 years | -72.9% | +833.6% | -24.2% |
5 y5 years | +69.6% | +181.7% | -29.2% |
ANIP CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -72.9% | +12.5% | -44.5% | +1379.1% | -24.2% | +332.6% |
5 y | 5 years | -72.9% | +69.6% | -90.5% | +1379.1% | -71.8% | +332.6% |
alltime | all time | -87.6% | >+9999.0% | -93.6% | -89.0% | >+9999.0% |
ANI Pharmaceuticals CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $5.44 M(+22.3%) | $19.25 M(+4.8%) |
June 2024 | - | $4.45 M(-2.9%) | $18.36 M(-11.5%) |
Mar 2024 | - | $4.58 M(-4.1%) | $20.74 M(+12.0%) |
Dec 2023 | $18.51 M(+12.5%) | $4.78 M(+5.0%) | $18.51 M(+9.7%) |
Sept 2023 | - | $4.55 M(-33.3%) | $16.87 M(-23.8%) |
June 2023 | - | $6.83 M(+190.1%) | $22.14 M(+33.1%) |
Mar 2023 | - | $2.35 M(-25.1%) | $16.63 M(+1.1%) |
Dec 2022 | $16.45 M(-30.4%) | $3.14 M(-68.0%) | $16.45 M(+20.3%) |
Sept 2022 | - | $9.81 M(+642.9%) | $13.68 M(+207.4%) |
June 2022 | - | $1.32 M(-39.3%) | $4.45 M(-82.3%) |
Mar 2022 | - | $2.18 M(+491.8%) | $25.08 M(+6.1%) |
Dec 2021 | $23.64 M(-65.4%) | $368.00 K(-36.9%) | $23.64 M(-6.9%) |
Sept 2021 | - | $583.00 K(-97.3%) | $25.39 M(-17.1%) |
June 2021 | - | $21.95 M(+2878.3%) | $30.61 M(+165.9%) |
Mar 2021 | - | $737.00 K(-65.2%) | $11.51 M(-83.1%) |
Dec 2020 | $68.32 M(+148.0%) | $2.12 M(-63.5%) | $68.32 M(+1.1%) |
Sept 2020 | - | $5.81 M(+104.0%) | $67.58 M(+6.1%) |
June 2020 | - | $2.85 M(-95.1%) | $63.70 M(-1.7%) |
Mar 2020 | - | $57.55 M(+4088.2%) | $64.81 M(+135.3%) |
Dec 2019 | $27.55 M(+152.5%) | $1.37 M(-28.9%) | $27.55 M(+1.4%) |
Sept 2019 | - | $1.93 M(-51.2%) | $27.18 M(+2.1%) |
June 2019 | - | $3.96 M(-80.5%) | $26.62 M(-7.9%) |
Mar 2019 | - | $20.29 M(+1914.4%) | $28.92 M(+165.0%) |
Dec 2018 | $10.91 M(-89.9%) | $1.01 M(-26.6%) | $10.91 M(-81.8%) |
Sept 2018 | - | $1.37 M(-78.1%) | $60.02 M(-1.8%) |
June 2018 | - | $6.25 M(+174.6%) | $61.13 M(+6.9%) |
Mar 2018 | - | $2.28 M(-95.5%) | $57.18 M(-47.1%) |
Dec 2017 | $107.99 M(-27.6%) | $50.12 M(+1920.8%) | $107.99 M(+82.2%) |
Sept 2017 | - | $2.48 M(+7.6%) | $59.27 M(+2.4%) |
June 2017 | - | $2.30 M(-95.7%) | $57.88 M(-50.4%) |
Mar 2017 | - | $53.09 M(+3722.5%) | $116.60 M(-21.8%) |
Dec 2016 | $149.06 M(+356.1%) | $1.39 M(+27.5%) | $149.06 M(+0.2%) |
Sept 2016 | - | $1.09 M(-98.2%) | $148.78 M(-14.7%) |
June 2016 | - | $61.03 M(-28.7%) | $174.46 M(+53.5%) |
Mar 2016 | - | $85.55 M(+7642.2%) | $113.62 M(+247.6%) |
Dec 2015 | $32.68 M(-8.6%) | $1.10 M(-95.9%) | $32.68 M(+2.4%) |
Sept 2015 | - | $26.77 M(>+9900.0%) | $31.92 M(+15.3%) |
June 2015 | - | $198.00 K(-95.7%) | $27.68 M(-0.2%) |
Mar 2015 | - | $4.61 M(+1264.5%) | $27.73 M(-22.4%) |
Dec 2014 | $35.75 M(>+9900.0%) | $338.00 K(-98.5%) | $35.75 M(+0.9%) |
Sept 2014 | - | $22.53 M(+8804.3%) | $35.45 M(+173.7%) |
June 2014 | - | $253.00 K(-98.0%) | $12.95 M(+1.0%) |
Mar 2014 | - | $12.63 M(>+9900.0%) | $12.83 M(+6615.2%) |
Dec 2013 | $191.00 K(-68.8%) | $29.00 K(-14.7%) | $191.00 K(-21.9%) |
Sept 2013 | - | $34.00 K(-73.4%) | $244.50 K(-63.8%) |
June 2013 | - | $128.00 K(+55.2%) | $675.90 K(+10.6%) |
Dec 2012 | $611.20 K | $82.50 K(-82.3%) | $611.20 K(+1.4%) |
Sept 2012 | - | $465.40 K(+5014.3%) | $603.00 K(+150.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2012 | - | $9100.00(-83.2%) | $240.30 K(-56.5%) |
Mar 2012 | - | $54.20 K(-27.1%) | $552.90 K(-23.2%) |
Dec 2011 | $719.90 K(+1035.5%) | $74.30 K(-27.7%) | $719.90 K(+5.9%) |
Sept 2011 | - | $102.70 K(-68.1%) | $680.10 K(+16.8%) |
June 2011 | - | $321.70 K(+45.4%) | $582.50 K(+110.4%) |
Mar 2011 | - | $221.20 K(+541.2%) | $276.80 K(+336.6%) |
Dec 2010 | $63.40 K(-61.7%) | $34.50 K(+576.5%) | $63.40 K(+53.9%) |
Sept 2010 | - | $5100.00(-68.1%) | $41.20 K(+12.0%) |
June 2010 | - | $16.00 K(+105.1%) | $36.80 K(+76.9%) |
Mar 2010 | - | $7800.00(-36.6%) | $20.80 K(-87.4%) |
Dec 2009 | $165.70 K(-74.6%) | $12.30 K(+1657.1%) | $165.70 K(-70.0%) |
Sept 2009 | - | $700.00(>+9900.0%) | $551.70 K(-18.3%) |
June 2009 | - | $0.00(-100.0%) | $675.10 K(-14.5%) |
Mar 2009 | - | $152.70 K(-61.7%) | $789.20 K(+21.2%) |
Dec 2008 | $651.10 K(+2114.6%) | $398.30 K(+221.0%) | $651.10 K(+137.5%) |
Sept 2008 | - | $124.10 K(+8.8%) | $274.20 K(+81.7%) |
June 2008 | - | $114.10 K(+681.5%) | $150.90 K(+243.0%) |
Mar 2008 | - | $14.60 K(-31.8%) | $44.00 K(+49.7%) |
Dec 2007 | $29.40 K(-25.2%) | $21.40 K(+2575.0%) | $29.40 K(+267.5%) |
Sept 2007 | - | $800.00(-88.9%) | $8000.00(-81.2%) |
June 2007 | - | $7200.00(>+9900.0%) | $42.50 K(+8.4%) |
Dec 2006 | $39.30 K(-41.7%) | $0.00(-100.0%) | $39.20 K(-35.4%) |
Sept 2006 | - | $35.30 K(+938.2%) | $60.70 K(+119.9%) |
June 2006 | - | $3400.00(+580.0%) | $27.60 K(-31.2%) |
Mar 2006 | - | $500.00(-97.7%) | $40.10 K(-40.6%) |
Dec 2005 | $67.40 K(-34.7%) | $21.50 K(+877.3%) | $67.50 K(-12.5%) |
Sept 2005 | - | $2200.00(-86.2%) | $77.10 K(-9.0%) |
June 2005 | - | $15.90 K(-43.0%) | $84.70 K(-15.9%) |
Mar 2005 | - | $27.90 K(-10.3%) | $100.70 K(-2.3%) |
Dec 2004 | $103.20 K(+1059.6%) | $31.10 K(+217.3%) | $103.10 K(+35.1%) |
Sept 2004 | - | $9800.00(-69.3%) | $76.30 K(+7.3%) |
June 2004 | - | $31.90 K(+5.3%) | $71.10 K(+81.4%) |
Mar 2004 | - | $30.30 K(+604.7%) | $39.20 K(+340.4%) |
Dec 2003 | $8900.00(-77.2%) | $4300.00(-6.5%) | $8900.00(+1.1%) |
Sept 2003 | - | $4600.00(+9.5%) | $8800.00(-77.4%) |
Dec 2002 | $39.00 K(-55.0%) | $4200.00(-53.3%) | $39.00 K(-13.7%) |
Sept 2002 | - | $9000.00(-2.2%) | $45.20 K(-49.8%) |
June 2002 | - | $9200.00(-44.6%) | $90.00 K(-11.1%) |
Mar 2002 | - | $16.60 K(+59.6%) | $101.20 K(+16.7%) |
Dec 2001 | $86.70 K(+100.7%) | $10.40 K(-80.7%) | $86.70 K(-1.5%) |
Sept 2001 | - | $53.80 K(+163.7%) | $88.00 K(+129.2%) |
June 2001 | - | $20.40 K(+871.4%) | $38.40 K(+12.9%) |
Mar 2001 | - | $2100.00(-82.1%) | $34.00 K(-21.3%) |
Dec 2000 | $43.20 K(+928.6%) | $11.70 K(+178.6%) | $43.20 K(+37.1%) |
Sept 2000 | - | $4200.00(-73.8%) | $31.50 K(+15.4%) |
June 2000 | - | $16.00 K(+41.6%) | $27.30 K(+141.6%) |
Mar 2000 | - | $11.30 K | $11.30 K |
Dec 1999 | $4200.00(-96.6%) | - | - |
Dec 1998 | $125.00 K | - | - |
FAQ
- What is ANI Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual CAPEX year-on-year change?
- What is ANI Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly CAPEX year-on-year change?
- What is ANI Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM CAPEX year-on-year change?
What is ANI Pharmaceuticals annual capital expenditures?
The current annual CAPEX of ANIP is $18.51 M
What is the all time high annual CAPEX for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual capital expenditures is $149.06 M
What is ANI Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, ANIP annual capital expenditures has changed by +$2.06 M (+12.49%)
What is ANI Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of ANIP is $5.44 M
What is the all time high quarterly CAPEX for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly capital expenditures is $85.55 M
What is ANI Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, ANIP quarterly capital expenditures has changed by +$890.00 K (+19.55%)
What is ANI Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of ANIP is $19.25 M
What is the all time high TTM CAPEX for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM capital expenditures is $174.46 M
What is ANI Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, ANIP TTM capital expenditures has changed by +$2.38 M (+14.09%)